$7.07 Million is the total value of Revelation Capital Management, LLC's 3 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 66.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OMIC | Sell | SINGULAR GENOMICS SYSTEMS INC | $5,409,000 | -61.4% | 1,415,846 | -36.2% | 76.54% | +49.4% |
| NPCE | Sell | NEUROPACE INC | $1,228,000 | -60.7% | 248,127 | -34.8% | 17.38% | +52.0% |
| ACCD | New | ACCOLADE INC | $430,000 | – | 58,050 | +100.0% | 6.08% | – |
| ME | Exit | 23ANDME HOLDING CO | $0 | – | -2,667,736 | -100.0% | -37.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SINGULAR GENOMICS SYSTEMS INC | 4 | Q3 2022 | 83.2% |
| NEUROPACE INC | 4 | Q3 2022 | 17.4% |
| 23ANDME HOLDING CO | 2 | Q1 2022 | 37.4% |
| AKILI INC | 1 | Q3 2022 | 13.1% |
| ACCOLADE INC | 1 | Q2 2022 | 6.1% |
| SOMALOGIC INC | 1 | Q4 2021 | 4.2% |
| NATERA INC | 1 | Q4 2021 | 0.7% |
| CVRX INC | 1 | Q4 2021 | 0.4% |
View Revelation Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
View Revelation Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.